AKT1 and cancer: Since chemotherapy primarily exerts its effects by inducing DNA damage, and cancer cells often evade this damage through activation of survival pathways such as PI3K/AKT ([23,24]), we hypothesized that concurrent inhibition of PI3K/AKT would suppress pro-survival signaling and thereby enhance chemotherapy-induced apoptosis.